Merck advances plan to shed consumer biz

Share this article:

The Wall Street Journal reported today that Merck will begin meeting with potential buyers of its consumer business next week and, citing unnamed sources, wrote that the price tag could be over $10 billion. Merck inherited its consumer business from Schering-Plough, which it acquired in 2009. In an investor note Wednesday night, ISI Group analyst Mark Schoenebaum stated that the final bid will likely be due in late March. Merck consumer products include Coppertone sunscreen, and Claritin allergy medication, among others.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.